Study yields positive results for breast cancer imaging agent

03/17/2013 | Yahoo

NuView Life Sciences' PET imaging agent for breast cancer, NLS-VPAC1, was able to detect 100% of malignant lesions and sentinel lymph nodes, according to findings presented at an international conference. Because of the agent's rapid uptake in tumors, the company is also investigating its use when labeled with the isotope gallium-68, which can be manufactured at local radiopharmacies. The agent may allow for noninvasive diagnosis of malignancies in the breast and other tissues, a researcher said.

View Full Article in:

Yahoo

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX